[STUDIES ON ANTITUMOR DRUGS. XI. TOXICITY AND THERAPEUTIC EFFECTS OF P-BIS-(2-CHLOROETHYL)-AMINOMETHYL PHENYLALANINE (AT-290)].
D000818:Animals; D000970:Antineoplastic Agents; D001777:Blood Coagulation; D002286:Carcinoma, Ehrlich Tumor; D005354:Fibrosarcoma; D006413:Hematopoietic System; D007962:Leukocytes; D015674:Mammary Neoplasms, Animal; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D009588:Nitrogen Mustard Compounds; D010600:Pharmacology; D010649:Phenylalanine; D051381:Rats; D012106:Research; D012509:Sarcoma; D012513:Sarcoma, Experimental
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D010649:Phenylalanine
BLOOD COAGULATION; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; FIBROSARCOMA; HEMATOPOIETIC SYSTEM; LEUKOCYTES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NITROGEN MUSTARD COMPOUNDS; PHARMACOLOGY; RATS; SARCOMA, EXPERIMENTAL; SARCOMA, JENSEN